Transfusion remains a key treatment for individuals with haemoglobinopathies, particularly in sickle cell disease, and this remains complicated by the significant risk of red cell alloimmunisation
Allergic reactions occur most commonly with plasma rich components. E.g. platelets, FFP and cryoprecipitate.
Platelet transfusions have the highest risk of bacterial contamination compared to other types of blood products
Remember: All details on the patient ID band must match exactly the details on the written authorisation for transfusion and the laboratory-generated label attached to the blood component pack.
If there are any discrepancies, the transfusion laboratory should be informed and the component must not be transfused until there has been an investigation and any discrepancies resolved.
IMPORTANT: If you are interrupted at any point, STOP, and start the checking procedure again. If any discrepancies (spelling, dates, illegibility) are noted DO NOT PROCEED. Seek advice e.g. discuss with the laboratory if appropriate and take corrective action before proceeding with the transfusion.
In the event of a delay return the component to the laboratory to prevent wastage.
Administration sets